Division of Social Pediatrics, Ege University Medical School, 35100 Bornova-Izmir, Turkey.
Int J Infect Dis. 2011 Jul;15(7):e475-80. doi: 10.1016/j.ijid.2011.03.016. Epub 2011 May 17.
We aimed to determine the rate of breakthrough varicella in Turkey, a country with low varicella vaccination coverage.
This study was conducted between April 2008 and March 2009 at the Well-Child Clinic at Ege University and pediatricians' offices. We collected information on vaccination status and varicella infection using a questionnaire. In order to elicit more details about the severity of illness, we interviewed all parents and reviewed the clinician records. Vaccination status was verified from the medical records or vaccination cards with dates.
A total of 2802 children were evaluated. Of these, 1683 had been vaccinated with a single dose of varicella vaccine and 1119 were unvaccinated. Among vaccinated children, 466 (27.7%) had breakthrough varicella. Vaccinated children tended to have mild varicella. However, about 25% of breakthrough cases had moderate or severe disease. Children who were vaccinated ≥ 5 years previously had a 3.7-fold higher risk of breakthrough disease than those who were vaccinated <5 years before. Vaccination at younger than 15 months of age was not significantly associated with an increased risk of breakthrough infection.
Breakthrough varicella is not rare in Turkey where varicella infections are common. A longer interval since vaccination may be a risk factor for developing breakthrough varicella. Children who had been vaccinated >5 years previously were at risk for breakthrough disease. A two-dose varicella vaccine policy may be needed to provide improved protection.
我们旨在确定土耳其(水痘疫苗接种覆盖率较低的国家)的突破性水痘发病率。
本研究于 2008 年 4 月至 2009 年 3 月在爱琴海大学和儿科医生办公室的幼儿保健诊所进行。我们使用问卷收集了关于疫苗接种状况和水痘感染的信息。为了更详细地了解疾病的严重程度,我们采访了所有家长并查阅了临床医生的记录。疫苗接种状况是通过医疗记录或带有日期的疫苗接种卡进行核实的。
共评估了 2802 名儿童。其中,1683 名儿童接种了一剂水痘疫苗,1119 名儿童未接种。在接种疫苗的儿童中,有 466 名(27.7%)出现了突破性水痘。接种疫苗的儿童的水痘通常较轻。但是,大约 25%的突破性病例患有中度或重度疾病。与接种疫苗<5 年的儿童相比,接种疫苗≥5 年的儿童发生突破性疾病的风险高 3.7 倍。接种疫苗年龄小于 15 个月与突破性感染风险增加无关。
在水痘感染较为普遍的土耳其,突破性水痘并不罕见。距上次接种时间较长可能是发生突破性水痘的危险因素。已接种疫苗>5 年的儿童有发生突破性疾病的风险。可能需要实施两剂水痘疫苗接种政策,以提供更好的保护。